Trump-Kennedy Health Industry Agreements Lack Enforcement Mechanisms, Face Implementation Uncertainty

Voluntary agreements between the Trump administration and health industry stakeholders on drug pricing, synthetic food dyes, and prior authorization have not been enforced since their announcement. The agreements were publicly touted as policy victories but contain no binding compliance mechanisms or regulatory authority. Implementation timelines remain unclear, and the voluntary nature of the commitments raises questions about whether the agreements will produce measurable changes to industry practices. The lack of enforcement structure leaves managed care organizations and other affected entities without clear compliance obligations or operational guidance.

Managed Care · Pharmacy